Insights On Pharmaceutical Production

  1. Accelerate Your pDNA And mRNA Process Development 11/13/2025

    Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.

  2. Using DSC And MDSC To Study Material Interactions Of APIs And Excipients 1/7/2026

    Thermal analysis reveals how particle size and morphology influence material interactions and stability. Learn how DSC and MDSC techniques uncover compatibility issues and guide better excipient selection.

  3. Productivity In mAb Capture 7/31/2025

    Discover how optimizing monoclonal antibody capture chromatography—especially resin selection—can dramatically improve cost efficiency, scalability, and productivity in therapeutic antibody manufacturing.

  4. Native SEC-MALS Characterization Using A Chromatography Data System 5/7/2026

    Native SEC‑MALS offers a calibration‑free way to accurately characterize peptide oligomers, helping scientists distinguish true higher‑order structures while avoiding bias.

  5. MilliporeSigma Bio-Expo Live February 2025: Downstream Bioprocessing 3/17/2025

    Advancements in single-use technologies are transforming antibody-drug conjugate manufacturing and offering increased flexibility. Examine key data, design considerations, operational benefits, and applications in ADC production.

  6. Collaborative Bioprocessing: Next-Gen mAb Downstream Manufacturing 9/23/2024

    Explore the bioprocessing template, operational paradigm, and the complexities of qualifying an advanced, highly automated bioprocessing train designed for the production of mAbs and other biologics.

  7. Discover A System That Can Be Used With Various Cell Culture Media 6/19/2026

    Evolving CAR T cell therapies are raising the bar for manufacturing. Advances in cell expansion and the shift to serum-free media are redefining how scalable, future-ready processes are designed.

  8. Shedding Light On Oligonucleotide Manufacturing 4/16/2025

    While oligonucleotide therapeutics show immense promise by targeting genetic codes, scaling up manufacturing presents unique challenges requiring innovative equipment solutions to meet growing demand.

  9. Elevating AAV Manufacturing WithTailored Cell Lines 9/19/2024

    Skillfully crafted cell lines can substantially enhance vector purity and yield. Watch to explore a portfolio of engineered cell lines and their potential to transform the landscape of AAV production.

  10. Enhancing mAb Production: Advanced Downstream Purification Strategies 9/1/2026

    Explore how process optimization can address downstream mAb manufacturing bottlenecks, reduce labor and consumable costs, and support more efficient production without compromising performance.